Transgenic mouse model for skin malignant melanoma - PubMed (original) (raw)

. 1998 Oct 8;17(14):1885-8.

doi: 10.1038/sj.onc.1202077.

Affiliations

• PMID: 9778055
• DOI: 10.1038/sj.onc.1202077

Transgenic mouse model for skin malignant melanoma

M Kato et al. Oncogene. 1998.

Abstract

We report here on a novel metallothionein-I (MT)/ret transgenic mouse line in which skin melanosis, benign melanocytic tumor and malignant melanoma metastasizing to distant organs develop stepwise. The process of tumor development and its malignant transformation in this line may resemble that of the human giant congenital melanocytic nevus that is present at birth and that frequently gives rise to malignant melanoma during aging. We observed an increase in the expression level and activity of the ret transgene during the disease progression. That increase in transgene expression accompanied an activation of mitogen-activated protein kinases (MAPKs) and c-Jun as well as matrix metalloproteinases. These results suggest that progressive dysregulation of the expression level of the ret transgene might play a crucial role in the malignant transformation of melanocytic tumors developed in the MT/ret transgenic mouse line.

PubMed Disclaimer

Similar articles

• A novel hairless mouse model for malignant melanoma.
  Thang ND, Yajima I, Nakagawa K, Tsuzuki T, Kumasaka MY, Ohgami N, Ly TB, Iwamoto T, Watanabe D, Kato M. Thang ND, et al. J Dermatol Sci. 2012 Mar;65(3):207-12. doi: 10.1016/j.jdermsci.2011.10.010. Epub 2011 Nov 25. J Dermatol Sci. 2012. PMID: 22169325
• Differential regulation of MMP-9 and TIMP-2 expression in malignant melanoma developed in metallothionein/RET transgenic mice.
  Asai M, Kato M, Asai N, Iwashita T, Murakami H, Kawai K, Nakashima I, Takahashi M. Asai M, et al. Jpn J Cancer Res. 1999 Jan;90(1):86-92. doi: 10.1111/j.1349-7006.1999.tb00670.x. Jpn J Cancer Res. 1999. PMID: 10076570 Free PMC article.
• A novel mouse model for de novo Melanoma.
  Kumasaka MY, Yajima I, Hossain K, Iida M, Tsuzuki T, Ohno T, Takahashi M, Yanagisawa M, Kato M. Kumasaka MY, et al. Cancer Res. 2010 Jan 1;70(1):24-9. doi: 10.1158/0008-5472.CAN-09-2838. Cancer Res. 2010. PMID: 20048069
• [Ultraviolet irradiation-mediated malignant melanoma induction with RET tyrosine kinase activation].
  Kato M, Takeda K, Kawamoto Y, Hossain K, Ohgami N, Yanagishita T, Ohshima Y, Kato Y, Ohgami K, Yamamori T, Tateyama K, Yamanoshita O. Kato M, et al. Nihon Eiseigaku Zasshi. 2007 Jan;62(1):3-8. doi: 10.1265/jjh.62.3. Nihon Eiseigaku Zasshi. 2007. PMID: 17334087 Review. Japanese.
• Proliferation and neoplastic transformation of pigment cells in metallothionein/ret transgenic mice.
  Takahashi M, Iwamoto T, Nakashima I. Takahashi M, et al. Pigment Cell Res. 1992 Nov;5(5 Pt 2):344-7. doi: 10.1111/j.1600-0749.1992.tb00560.x. Pigment Cell Res. 1992. PMID: 1292018 Review.

Cited by

• PD-1 and CTLA-4 serve as major gatekeepers for effector and cytotoxic T-cell potentiation by limiting a CXCL9/10-CXCR3-IFNγ positive feedback loop.
  Abdala-Saleh N, Lugassy J, Shivakumar-Kalvhati A, Turky A, Abu Ras S, Razon H, Berger N, Bar-On D, Bar-On Y, Taura T, Wilson D, Karin N. Abdala-Saleh N, et al. Front Immunol. 2024 Oct 15;15:1452212. doi: 10.3389/fimmu.2024.1452212. eCollection 2024. Front Immunol. 2024. PMID: 39474427 Free PMC article.
• Crosslinking of Ly6a metabolically reprograms CD8 T cells for cancer immunotherapy.
  Maliah A, Santana-Magal N, Parikh S, Gordon S, Reshef K, Sade Y, Khateeb A, Richter A, Gutwillig A, Parikh R, Golan T, Krissi M, Na M, Binshtok G, Manich P, Elkoshi N, Grisaru-Tal S, Zemser-Werner V, Brenner R, Vaknine H, Nizri E, Moyal L, Amitay-Laish I, Rosemberg L, Munitz A, Kronfeld-Schor N, Shifrut E, Kobiler O, Madi A, Geiger T, Carmi Y, Levy C. Maliah A, et al. Nat Commun. 2024 Sep 27;15(1):8354. doi: 10.1038/s41467-024-52079-x. Nat Commun. 2024. PMID: 39333093 Free PMC article.
• ComplexEye: a multi-lens array microscope for high-throughput embedded immune cell migration analysis.
  Cibir Z, Hassel J, Sonneck J, Kowitz L, Beer A, Kraus A, Hallekamp G, Rosenkranz M, Raffelberg P, Olfen S, Smilowski K, Burkard R, Helfrich I, Tuz AA, Singh V, Ghosh S, Sickmann A, Klebl AK, Eickhoff JE, Klebl B, Seidl K, Chen J, Grabmaier A, Viga R, Gunzer M. Cibir Z, et al. Nat Commun. 2023 Dec 11;14(1):8103. doi: 10.1038/s41467-023-43765-3. Nat Commun. 2023. PMID: 38081825 Free PMC article.
• Environmental signals perceived by the brain abate pro-metastatic monocytes by dampening glucocorticoids receptor signaling.
  Canali MM, Guyot M, Simon T, Daoudlarian D, Chabry J, Panzolini C, Petit-Paitel A, Hypolite N, Nicolas S, Bourdely P, Schmid-Antomarchi H, Schmid-Alliana A, Soria J, Karimdjee Soilihi B, Hofman P, Prevost-Blondel A, Kato M, Mougneau E, Glaichenhaus N, Blancou P. Canali MM, et al. Cancer Cell Int. 2023 Feb 1;23(1):15. doi: 10.1186/s12935-023-02855-4. Cancer Cell Int. 2023. PMID: 36726173 Free PMC article.
• Syntaphilin Regulates Neutrophil Migration in Cancer.
  Fu S, Deng H, Bertolini I, Perego M, Chen ES, Sanseviero E, Mostafa A, Alicea-Torres K, Garcia-Gerique L, Stone EL, Kossenkov AV, Schug ZT, Nam B, Mulligan C, Altieri DC, Nefedova Y, Gabrilovich DI. Fu S, et al. Cancer Immunol Res. 2023 Mar 1;11(3):278-289. doi: 10.1158/2326-6066.CIR-22-0035. Cancer Immunol Res. 2023. PMID: 36548516 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Medical

  • MedlinePlus Health Information

• Molecular Biology Databases

  • Mouse Genome Informatics (MGI)

• Miscellaneous

  • NCI CPTAC Assay Portal